Samsara BioCapital, L.P. (CIK 0001699737)

Latest company ownership

Shares held
6,788,609
Last filed at
Oct 18, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q4 2025Q4
Shares held
5,674,916
Last filed at
Mar 17, 2025
Confidence Score
50.6
2025Q4
Confidence Score History
2023Q1 2025Q4
NGNE - Neurogene Inc.
Role: 10% Owner
Shares held
1,717,127
Last filed at
Nov 27, 2024
Confidence Score
50.1
2025Q4
Confidence Score History
2024Q4 2025Q4
Shares held
22,753
Last filed at
Jul 1, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 13, 2025 Mar 17, 2025 Mineralys Therapeutics, Inc. 10% Owner Buy 100.0 +600,000 11.82% ✗ $8.1M
Nov 26, 2024 Nov 27, 2024 Neurogene Inc. 10% Owner Buy 92.5 +48,770 2.92% ✗ $1.3M
Feb 12, 2024 Feb 14, 2024 Mineralys Therapeutics, Inc. 10% Owner Buy 100.0 +555,555 12.29% ✗ $7.5M
Oct 16, 2023 Oct 18, 2023 Scholar Rock Holding Corp 10% Owner Buy 100.0 +2,189,781 47.62% ✗ $15M
Feb 14, 2023 Feb 16, 2023 Mineralys Therapeutics, Inc. 10% Owner Buy 100.0 +937,500 26.17% ✗ $15M
Apr 11, 2022 Apr 13, 2022 LENZ Therapeutics, Inc. 10% Owner Buy 95.0 +424,464 5.26% ✗ $1.7M
Jan 21, 2022 Jan 25, 2022 LENZ Therapeutics, Inc. 10% Owner Buy 87.5 +123,000 1.55% ✗ $1.1M
Jan 19, 2022 Jan 21, 2022 LENZ Therapeutics, Inc. 10% Owner Buy 85.0 +97,670 1.25% ✗ $888.7K
Dec 15, 2021 Dec 20, 2021 LENZ Therapeutics, Inc. 10% Owner Buy 65.0 +22,329 0.29% ✗ $227.5K
Nov 22, 2021 Nov 24, 2021 LENZ Therapeutics, Inc. 10% Owner Buy 92.5 +201,685 2.66% ✗ $2M
Oct 13, 2021 Oct 15, 2021 LENZ Therapeutics, Inc. 10% Owner Buy 75.0 +50,800 0.67% ✗ $667.7K
Oct 6, 2021 Oct 8, 2021 LENZ Therapeutics, Inc. 10% Owner Buy 87.5 +145,496 1.97% ✗ $2M
Jun 29, 2021 Jul 1, 2021 LENZ Therapeutics, Inc. 10% Owner Buy 96.3 +500,000 7.21% ✗ $8.5M